#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small cell lung cancer extensive stage IPEX syndrome Congenital pseudarthrosis HER2 mutant non-small cell lung cancer Hepatic angiosarcoma Dupuytren's contracture Myotonic dystrophy Malignant oligodendroglioma Phaeochromocytoma Immunoglobulin G4 related disease Drug eruption Mastocytosis Osteosarcoma metastatic Systemic sclerosis pulmonary Angiosarcoma More trials…

    Learn about Rare Diseases

    IgA nephropathy – Treatment Stevens-Johnson syndrome – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Life with Disease Cytokine release syndrome – Life with Disease Primary biliary cholangitis – Basic Information Loeys-Dietz syndrome – Diagnostics Marginal zone lymphoma – Basic Information Tuberous sclerosis complex – Treatment Thrombotic thrombocytopenic purpura – Basic Information IgA nephropathy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Encorafenib Empasiprubart Roxadustat Cdr132L Prilocaine Amlodipine Besilate Abc-15A-116 Ttx-030 Xtmab-16 Macitentan Cx-044933 Furosemide Ph. Eur. Decitabine Cat Epithelia Sodium Zirconium Cyclosilicate Esomeprazole Db-1303 Vinflunine Crgd-Zw800-1 Tasipimidine More therapies…

    Learn about Your Condition

    Diffuse large B-cell lymphoma Dementia Alzheimer's type Pancreatitis relapsing Glucose tolerance impaired Frostbite Rectosigmoid cancer Endometrial cancer stage IV Anaemia of pregnancy Sickle cell anaemia Chronic spontaneous urticaria Meningioma malignant Multiple sclerosis relapse Papilloma viral infection Bone metabolism disorder HIV infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

HIV infection

  • Study on Switching HIV Treatment to Dolutegravir/Lamivudine in Patients Aged 50+ with Virologic Suppression

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Dolutegravir Sodium
    • Lamivudine
    • Bictegravir
    Austria Belgium France Germany Italy The Netherlands +2

  • Study on the Effectiveness and Safety of Lamivudine, Dolutegravir Sodium, Cabotegravir, and Rilpivirine for Adults with HIV-1 Who Have Not Taken Antiretroviral Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Dolutegravir Sodium
    • Lamivudine
    • Cabotegravir
    France Germany Italy Spain

  • Study on the Effects of GSK4004280 and GSK4011499 in Adults with HIV Infections

    Not recruiting

    2 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Gsk4004280
    • Gsk4011499
    France Germany Italy Spain

  • Study on the Effects of GSK3739937 for Adults with HIV-1 Who Have Not Yet Received Treatment

    Not recruiting

    2 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Gsk3739937
    Greece Italy Poland Spain

  • Study Comparing Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Treatment in Adults New to Antiretroviral Therapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Dolutegravir Sodium
    • Lamivudine
    • Bictegravir
    Belgium Denmark France Germany Greece Ireland +5

  • Study on the Effectiveness of Rilpivirine-Based Treatment for HIV Patients with Metabolic Liver Disease Using Dolutegravir, Rilpivirine, and Emtricitabine/Tenofovir Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Dolutegravir Sodium
    • Rilpivirine Hydrochloride
    • Tenofovir Disoproxil Fumarate
    Spain
Previous Page
1 … 9 10 11 12
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!